Latinx Investments

347 posts

Latinx Investments

Latinx Investments

@InvestorLatin

Tech $ZETA $AMZN Finance $DLO Pharma/Biotech $AQST $ABEO $HROW $OCUL $RNAC

Katılım Temmuz 2025
196 Takip Edilen52 Takipçiler
Culper
Culper@CulperResearch·
NEW: We are short ADMA Biologics $ADMA. We believe the ASCENIV growth story is in reality a story of channel stuffing and an undisclosed related party distributor. Real revenues declined 3% in 2025 vs. 20% reported growth. It's already over. Full report available on our website.
Culper tweet media
English
8
6
39
19.3K
Yeimis Echeverry
Yeimis Echeverry@YeimisAriel·
Lo que se comió Luis Suárez lo metía Dayro Moreno acabado de salir del estanco, vomitado, enguayabado y caminando con un botello en la mano.
Español
19
123
1.2K
31.2K
Latinx Investments retweetledi
Common Sense Investor (CSI)
Common Sense Investor (CSI)@commonsenseplay·
WE ARE IN THE PERFECT SET UP FOR A STOCK MARKET CRASH. 1. Consumers are still spending money they don't have. - Consumer spending makes up 70% of GDP - But personal savings are near record lows and - Credit card balances are at record highs - This is not sustainable and when consumers stop spending - earnings fall and markets follow! 2. The labor market has persevered but is showing cracks. - Hiring has slowed significantly and layoffs are increasing - Its not a strong labor market, its a lagging labor market which always happens right before downturns! - Less people employed means less consumer spending Rate cuts won't save us this time! Will Private Credit be that single catalyst? Here is the cycle of false confidence that always happens right before the real crash, and it's happening RIGHT NOW!
English
33
63
280
22.2K
Nate Endicott
Nate Endicott@EndicottInvests·
I guess $ZETA will survive Claude’s wrath today Market needs to make up its mind
Nate Endicott tweet media
English
4
0
38
5.8K
Latinx Investments retweetledi
In Honour Of Thomas W Phelps
In Honour Of Thomas W Phelps@HOThomasWPhelps·
Atopic Dermatitis Landscape: Updated earlier 5-axis radar graph w/ actual data for: EASI-75, Safety, Durability, Treg, Failed Patients ⤵️ $SNY $REGN #Dupilumab,IL-4 $ABBV #Upadacitinib, JAKi $APGE APG777, IL-13 $NKTR #Rezpeg, IL-2 $KYMR KT-621, STAT6 $CRVS #Soquelitinib, ITKi
In Honour Of Thomas W Phelps tweet media
In Honour Of Thomas W Phelps@HOThomasWPhelps

Summary graphic of atopic dermatitis drugs/targets by benefit/treatment profile: SOC benchmarks: #Dupilumab $SNY $REGN and #Upadacitinib $ABBV Compare to: Injectables in Ph2b trials #APG777 $APGE #Rezpeg $NKTR Oral drugs in Ph2b trials #soquelitinib $CRVS KT-621 $KYMR

English
3
10
50
19.2K
Big C
Big C@BigChodu·
Any bargains biotech experts?
English
7
0
3
2K
BIOTECH SCANNER
BIOTECH SCANNER@BIOTECHSCANNER·
$IOVA- The market will rip big time once this Iran conflict is resolved. It will be wild. Shorts will absolutely be destroyed. If you are getting $IOVA shares at the current price ($3.62) consider yourself lucky. $10 by end of 2026 👀
English
5
3
49
3.5K
Culper
Culper@CulperResearch·
11) It gets worse... $ADMA appears to distribute ASCENIV via Genesis BioPharma Services ("Gen Bio"), an IVIG distributor controlled by Vice Chairman Jerrold Grossman (father of CEO Adam Grossman) operating from ADMA's own HQ. $ADMA has never disclosed any RPTs with Gen Bio.
Culper tweet mediaCulper tweet mediaCulper tweet media
English
4
0
2
11.5K
Latinx Investments retweetledi
Stymbol
Stymbol@stymbol789·
$ZETA launched Athena for general availability today, arguably the most important product catalyst to date, yet the stock sold off amid a broader software pullback following an $AMZN internal automation headline. That AWS headline actually reinforces the thesis: enterprises are replacing human workflows with AI agents, which is exactly the buying psychology Zeta needs to accelerate its replacement cycle against legacy marketing clouds. Athena is not a new narrative but the productization of a strategy built over the past year, grounded in the empirical precedent that ZOE adopters spent 200-225% more on the platform, with Athena potentially driving a higher ceiling by layering execution and interface on top of decisioning. None of this is in FY26 guidance, the stock is not pricing it, and Marigold is simultaneously feeding high-value enterprise logos into a platform that just became meaningfully more compelling. Long $ZETA, NFA.
English
0
1
3
361
Latinx Investments
Latinx Investments@InvestorLatin·
@EchoAnalysis Very accurate my friend. Thankfully I sold a couple days ago and will buy back at the 200WMA. By the way, I would recommend you to look at $OCUL. Does the chart look primed?? 😉
English
0
0
3
276
RojoSinCensura
RojoSinCensura@RojoSinCensura·
Mosquera mierda siempre
Español
7
1
91
2.3K